Jiangsu Kanion Pharmaceutical Co Ltd (600557) — Net Asset Quality Index
Jiangsu Kanion Pharmaceutical Co Ltd (600557) has a Net Asset Quality Index of 72.9% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥6.74 Billion minus total liabilities of CN¥1.83 Billion yields net assets of CN¥4.91 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read how much debt does Jiangsu Kanion Pharmaceutical Co Ltd carry for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Jiangsu Kanion Pharmaceutical Co Ltd Net Asset Quality Index Over Time (1999–2024)
This chart shows how Jiangsu Kanion Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 26 annual periods from 1999 to 2024. As of September 2025, the index stands at 72.9%, representing net assets of CN¥4.91 Billion against total assets of CN¥6.74 Billion CNY. For live market cap and overall valuation, see how much is Jiangsu Kanion Pharmaceutical Co Ltd worth.
Annual Net Asset Quality Index for Jiangsu Kanion Pharmaceutical Co Ltd (1999–2024)
The table below presents the year-by-year Net Asset Quality Index for Jiangsu Kanion Pharmaceutical Co Ltd from 1999 to 2024, covering 26 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Jiangsu Kanion Pharmaceutical Co Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 68.1% | CN¥4.71 Billion | CN¥6.91 Billion | CN¥2.20 Billion | ▼ -7.5 pp |
| 2023 | 75.6% | CN¥5.38 Billion | CN¥7.12 Billion | CN¥1.74 Billion | ▲ +3.0 pp |
| 2022 | 72.6% | CN¥4.93 Billion | CN¥6.80 Billion | CN¥1.86 Billion | ▼ -1.7 pp |
| 2021 | 74.3% | CN¥4.47 Billion | CN¥6.02 Billion | CN¥1.55 Billion | ▲ +3.6 pp |
| 2020 | 70.7% | CN¥4.33 Billion | CN¥6.12 Billion | CN¥1.79 Billion | ▲ +3.8 pp |
| 2019 | 66.9% | CN¥4.09 Billion | CN¥6.11 Billion | CN¥2.02 Billion | ▼ -2.6 pp |
| 2018 | 69.5% | CN¥3.89 Billion | CN¥5.60 Billion | CN¥1.71 Billion | ▲ +2.8 pp |
| 2017 | 66.6% | CN¥3.59 Billion | CN¥5.39 Billion | CN¥1.80 Billion | ▼ -1.2 pp |
| 2016 | 67.8% | CN¥3.21 Billion | CN¥4.73 Billion | CN¥1.52 Billion | ▲ +1.1 pp |
| 2015 | 66.7% | CN¥2.87 Billion | CN¥4.30 Billion | CN¥1.43 Billion | ▲ +5.2 pp |
| 2014 | 61.5% | CN¥2.56 Billion | CN¥4.15 Billion | CN¥1.60 Billion | ▲ +5.2 pp |
| 2013 | 56.4% | CN¥1.93 Billion | CN¥3.43 Billion | CN¥1.50 Billion | ▲ +3.5 pp |
| 2012 | 52.8% | CN¥1.65 Billion | CN¥3.12 Billion | CN¥1.47 Billion | ▼ -4.3 pp |
| 2011 | 57.1% | CN¥1.47 Billion | CN¥2.58 Billion | CN¥1.11 Billion | ▼ -5.5 pp |
| 2010 | 62.6% | CN¥1.24 Billion | CN¥1.99 Billion | CN¥743.19 Million | ▼ -12.0 pp |
| 2009 | 74.6% | CN¥1.08 Billion | CN¥1.45 Billion | CN¥367.23 Million | ▲ +1.7 pp |
| 2008 | 72.8% | CN¥954.72 Million | CN¥1.31 Billion | CN¥355.85 Million | ▲ +18.8 pp |
| 2007 | 54.1% | CN¥557.95 Million | CN¥1.03 Billion | CN¥473.81 Million | ▲ +1.4 pp |
| 2006 | 52.7% | CN¥492.91 Million | CN¥936.11 Million | CN¥443.19 Million | ▲ +6.4 pp |
| 2005 | 46.2% | CN¥457.89 Million | CN¥990.51 Million | CN¥532.62 Million | ▼ -6.5 pp |
| 2004 | 52.8% | CN¥414.10 Million | CN¥784.98 Million | CN¥370.88 Million | ▲ +4.6 pp |
| 2003 | 48.2% | CN¥374.88 Million | CN¥778.43 Million | CN¥403.56 Million | ▼ -30.1 pp |
| 2002 | 78.2% | CN¥333.38 Million | CN¥426.07 Million | CN¥92.69 Million | ▲ +36.6 pp |
| 2001 | 41.6% | CN¥73.91 Million | CN¥177.52 Million | CN¥103.61 Million | ▲ +9.2 pp |
| 2000 | 32.4% | CN¥57.01 Million | CN¥175.93 Million | CN¥118.92 Million | ▲ +5.7 pp |
| 1999 | 26.7% | CN¥41.54 Million | CN¥155.38 Million | CN¥113.84 Million | — |